SAEYY OTC
Redcare Pharmacy N.V.
1W: +18.8%
1M: +12.9%
3M: +8.6%
YTD: +5.5%
1Y: -4.7%
3Y: -20.2%
5Y: -59.2%
$8.20
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Income Trends
Revenue
$2.8B
+19.2% ▲
5Y CAGR: +23.9%
Gross Profit
$570M
+4.5% ▲
5Y CAGR: +21.0%
Operating Income
-$23M
+41.4% ▲
Net Income
-$36M
+20.3% ▲
EPS (Diluted)
$-0.18
+21.1% ▲
EBITDA
$44M
+441.4% ▲
5Y CAGR: +32.1%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $1.1B | $1.2B | $1.8B | $2.4B | $2.8B |
| YoY Growth | +9.5% | +13.6% | +49.4% | +31.8% | +19.2% |
| Cost of Revenue | $794M | $873M | $1.4B | $1.8B | $2.3B |
| Gross Profit | $267M | $332M | $440M | $546M | $570M |
| Gross Margin | 25.1% | 27.5% | 24.5% | 23.0% | 20.2% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $197M | $244M | $267M | $581M | $427M |
| Operating Expenses | $310M | $401M | $458M | $585M | $593M |
| Operating Income | -$66M | -$69M | -$17M | -$39M | -$23M |
| Operating Margin | -6.2% | -5.7% | -1.0% | -1.6% | -0.8% |
| Interest Expense | $9M | $9M | $15M | $8M | $19M |
| Income Before Tax | -$78M | -$84M | -$14M | -$48M | -$46M |
| Tax Expense | -$4M | -$6M | -$3M | -$1M | -$8M |
| Net Income | -$74M | -$78M | -$12M | -$45M | -$36M |
| Net Margin | -7.0% | -6.4% | -0.7% | -1.9% | -1.3% |
| EPS (Diluted) | $-0.41 | $-0.43 | $-0.06 | $-0.23 | $-0.18 |
| EBITDA | -$37M | -$31M | $51M | -$13M | $44M |
| Shares Outstanding | 179M | 180M | 192M | 201M | 201M |